Health news
The Food and Drug Administration (FDA) has approved Quviviq (daridorexant) for the treatment of adults with insomnia characterized by difficulties with sleep onset and/or sleep maintenance. Daridorexant is a dual orexin receptor antagonist designed to…
In the United States, 20% of employees work during shifts that are outside of the traditional 9:00 AM to 5:00 PM schedule, including many in the health care industry.1-3 Work schedules may include early morning, evening,…
A pilot trial for veterans with alcohol use disorder (AUD) who report symptoms of insomnia will test the feasibility and acceptability of cognitive behavioral therapy for insomnia (CBT-I). The protocol for this study was published…
Intermittent dosing of zolpidem with placebo after one month of full dose nightly zolpidem is an effective acute and extended treatment for patients with chronic insomnia while using 50% less medication, according to study results…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021